Qiagen, Suzhou, China
24 May 2013
Jean-Claude Muller joins board of Qiagen Suzhou
Dr Muller, special advisor to Innovation & International Relationship, has been named to the board of directors of Qiagen Suzhou, a new translational medicine R&D corporation in Suzhou, China. The center will accelerate the discovery and validation of biomarkers and create companion diagnostics for companies operating on the Chinese market. Dr Muller is a former senior vice-president in R&D at Sanofi. He is also a member of the Editorial Board at MedNous.